Abstract
S-2150 is a new 1,5-benzothiazepine derivative possessing both calcium channel-blocking and alpha 1-adrenoceptor-blocking effects. In isolated rat thoracic aorta precontracted with KCl (18 mM), the 50% inhibitory concentration (IC50) value was 190 nM for S-2150, which was similar to that of diltiazem. In aorta precontracted with phenylephrine (0.3 microM), IC50 values of S-2150 and diltiazem were 29 nM and > 10 microM, respectively. The relative contribution of calcium channel-blocking and alpha 1-adrenoceptor-blocking activities to hypotension was determined by using anesthetized rats before and after masking of the alpha 1-receptors with prazosin. The hypotensive effect of S-2150 [0.3 and 1 mg/kg intravenously (i.v.)] was attenuated by 40% after prazosin treatment, whereas that of diltiazem was not. In conscious spontaneously hypertensive rats (SHRs), renal hypertensive rats, and normotensive rats, S-2150 [10, 30, and 60 mg/kg orally (p.o.)] caused dose-dependent hypotensive effects. The effect of S-2150 was 4-7 times more potent than that of diltiazem. There were no changes in the hypotensive effects with consecutive administration of S-2150 during 6-8 weeks in SHRs and stroke-prone SHRs (SHRSPs). In SHRSPs, S-2150 reduced t...Continue Reading
References
Dec 1, 1991·Trends in Pharmacological Sciences·G Zernig
Oct 1, 1990·Hypertension·R HenryM P Printz
Apr 1, 1988·Journal of Cardiovascular Pharmacology·H C StantonG S Poindexter
Jan 1, 1988·Annual Review of Pharmacology and Toxicology·D F Bohr, R C Webb
Jan 1, 1989·Journal of Cardiovascular Pharmacology·J GriesB W Neumann
Sep 1, 1985·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·H NaritaT Morita
Dec 1, 1987·Cardiovascular Drugs and Therapy·T IsshikiE D Frohlich
Jul 1, 1987·Journal of Pharmacological Methods·S MatsudaM Ueda
Jan 1, 1983·Circulation·G H BardyR E Ideker
Nov 5, 1981·European Journal of Pharmacology·C Y Kwan, E E Daniel
May 30, 1980·European Journal of Pharmacology·H IshiiT Nose
Dec 1, 1993·Journal of Cardiovascular Pharmacology·H OkamuraM Kurokawa
Jul 1, 1995·Journal of Cardiovascular Pharmacology·T SugimotoT Karasawa
Apr 1, 1995·Japanese Journal of Pharmacology·S FurutaT Yoneta
Sep 1, 1994·Japanese Journal of Pharmacology·T KatoM Sakanashi
Mar 1, 1993·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·J L RodicioL M Ruilope
Oct 1, 1996·Journal of Cardiovascular Pharmacology·M MasuiK Iwaki